These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25242634)

  • 1. Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis.
    Nasiri MJ; Dabiri H; Darban-Sarokhalil D; Rezadehbashi M; Zamani S
    Am J Infect Control; 2014 Nov; 42(11):1212-8. PubMed ID: 25242634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review.
    Pourakbari B; Mamishi S; Mohammadzadeh M; Mahmoudi S
    Front Microbiol; 2016; 7():1139. PubMed ID: 27516756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary ethambutol resistance among Iranian pulmonary tuberculosis patients: a systematic review.
    Nasiri MJ; Imani Fooladi AA; Dabiri H; Pormohammad A; Salimi Chirani A; Dadashi M; Houri H; Heidary M; Feizabadi MM
    Ther Adv Infect Dis; 2016 Oct; 3(5):133-138. PubMed ID: 28149517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the Evolution of Clinical Trials on Drug-Resistant Tuberculosis: A Bibliometric Overview (1965-2023).
    Dagli N; Haque M; Kumar S
    Cureus; 2024 Feb; 16(2):e55190. PubMed ID: 38425326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Tuberculosis among People Who Use Drugs in Iran: A Systematic Review and Meta-analysis.
    Rafiemanesh H; Shadloo B; Amin-Esmaeili M; Rahimi Y; Gholami J; Rahimi-Movaghar A
    Addict Health; 2023 Jul; 15(3):219-227. PubMed ID: 38026719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rare multidrug cervical tubercular lymphadenitis in an infant from Iran: A case report and literature review.
    Keikha M; Askarizadeh F; Sasan MS; Joghatayee H; Soleimanpour S
    Clin Case Rep; 2021 Feb; 9(2):681-685. PubMed ID: 33598225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.
    Patel RV; Riyaz SD; Park SW
    Curr Top Med Chem; 2014; 14(16):1866-74. PubMed ID: 25262806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis around the world: what progress has been made?
    Falzon D; Mirzayev F; Wares F; Baena IG; Zignol M; Linh N; Weyer K; Jaramillo E; Floyd K; Raviglione M
    Eur Respir J; 2015 Jan; 45(1):150-60. PubMed ID: 25261327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis.
    Abbasian S; Heidari H; Abbasi Tadi D; Kardan-Yamchi J; Taji A; Darbandi A; Asadollahi P; Maleki A; Kazemian H
    J Clin Tuberc Other Mycobact Dis; 2024 May; 35():100430. PubMed ID: 38560029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of drug resistant
    Ansarin K; Sahebi L
    Iran J Microbiol; 2022 Jun; 14(3):285-290. PubMed ID: 37124845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serosal membrane tuberculosis in Iran: A comprehensive review of evidences.
    Ebrahimzadeh A; Pagheh AS; Mousavi T; Fathi M; Moghaddam SGM
    J Clin Tuberc Other Mycobact Dis; 2023 May; 31():100354. PubMed ID: 36874623
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Reta MA; Tamene BA; Abate BB; Mensah E; Maningi NE; Fourie PB
    Trop Med Infect Dis; 2022 Oct; 7(10):. PubMed ID: 36288041
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiological Characteristics and Their Influencing Factors Among Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Survey Study From Drug Resistance Surveillance in East China.
    Wu Q; Wang M; Zhang Y; Wang W; Ye TF; Liu K; Chen SH
    Front Public Health; 2021; 9():777000. PubMed ID: 35141185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis.
    Bahraminia F; Azimi T; Zangiabadian M; Nasiri MJ; Goudarzi M; Dadashi M; Imani Fooladi AA
    Iran J Basic Med Sci; 2021 Jun; 24(6):720-725. PubMed ID: 34630948
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis.
    Hajissa K; Marzan M; Idriss MI; Islam MA
    Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatio-temporal epidemiology of the tuberculosis incidence rate in Iran 2008 to 2018.
    Kiani B; Raouf Rahmati A; Bergquist R; Hashtarkhani S; Firouraghi N; Bagheri N; Moghaddas E; Mohammadi A
    BMC Public Health; 2021 Jun; 21(1):1093. PubMed ID: 34098917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated systematic review and meta-analysis on
    Khademi F; Sahebkar A
    Iran J Basic Med Sci; 2021 Apr; 24(4):428-436. PubMed ID: 34094023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018.
    Bahizi G; Majwala RK; Kisaka S; Nyombi A; Musisi K; Kwesiga B; Bulage L; Ario AR; Turyahabwe S
    Antimicrob Resist Infect Control; 2021 May; 10(1):76. PubMed ID: 33964986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of migration on tuberculosis epidemiological indicators in low and medium tuberculosis incidence countries: A systematic review.
    Jackson S; Kabir Z; Comiskey C
    J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100225. PubMed ID: 33681478
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.